Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)
Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.
in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.
|Myocardial Ischemia||Other: diagnosis reassessment Other: Diagnosis strategy and subsequent therapeutic reassessment|
|Study Design:||Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
|Official Title:||Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly|
- therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly [ Time Frame: during hospitalization ]
- part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months [ Time Frame: during hospitalization ]
|Study Start Date:||November 2004|
|Study Completion Date:||November 2006|
|Primary Completion Date:||November 2005 (Final data collection date for primary outcome measure)|
Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.
Other: diagnosis reassessment
Strategy of diagnosis reassessment following a decision tree.
Other Name: no other names to specifiedOther: Diagnosis strategy and subsequent therapeutic reassessment
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy
Please refer to this study by its ClinicalTrials.gov identifier: NCT00224575
|Paris, France, 75018|
|Principal Investigator:||legrain sylvie||APHP|